Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

Study to examine the concentration of the study drug, tigecycline, in human bone samples following the administration of multiple doses.

Key facts

Study ID
NCT00376324
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
36
Starts
2006-09-01
Expected to finish
2008-10-01
Last updated by the study team
2009-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.